Canada - anglais - Health Canada

pfizer canada ulc - conjugated estrogens - tablet (extended-release) - 0.625mg - conjugated estrogens 0.625mg - estrogens

Canada - anglais - Health Canada

pfizer canada ulc - conjugated estrogens - tablet (extended-release) - 1.25mg - conjugated estrogens 1.25mg - estrogens

Canada - anglais - Health Canada

pfizer canada ulc - conjugated estrogens; bazedoxifene (bazedoxifene acetate) - tablet (immediate and extended release) - 0.45mg; 20mg - conjugated estrogens 0.45mg; bazedoxifene (bazedoxifene acetate) 20mg - estrogen agonist-antagonists

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - conjugated estrogens 0.625mg (15mg as a dessication with lactose, includes 3% overage.);  ; medroxyprogesterone acetate 2.6mg (includes 4% overage.); conjugated estrogens 0.625mg (15mg as a dessication with lactose, includes 3% overage.); medroxyprogesterone acetate 2.6mg (includes 4% overage.) - tablet - active: conjugated estrogens 0.625mg (15mg as a dessication with lactose, includes 3% overage.)   medroxyprogesterone acetate 2.6mg (includes 4% overage.) excipient: calcium sulfate carnauba wax glyceryl mono-oleate iron oxide red lactose monohydrate macrogol 20000 magnesium stearate methylcellulose microcrystalline cellulose   opacode black s-8-27741 povidone shellac stearic acid sucrose     titanium dioxide   active: conjugated estrogens 0.625mg (15mg as a dessication with lactose, includes 3% overage.) medroxyprogesterone acetate 2.6mg (includes 4% overage.) excipient: calcium sulfate carnauba wax glyceryl mono-oleate iron oxide red lactose monohydrate macrogol 20000 magnesium stearate methylcellulose microcrystalline cellulose opacode black s-8-27741 povidone shellac stearic acid sucrose titanium dioxide  

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - conjugated estrogens 0.625mg (15mg as a dessication with lactose. includes 3% overage.);  ; medroxyprogesterone acetate 5mg (includes 4% overage); conjugated estrogens 0.625mg (15mg as a dessication with lactose. includes 3% overage.); medroxyprogesterone acetate 5mg (includes 4% overage) - tablet - active: conjugated estrogens 0.625mg (15mg as a dessication with lactose. includes 3% overage.)   medroxyprogesterone acetate 5mg (includes 4% overage) excipient: calcium sulfate carnauba wax glyceryl mono-oleate iron oxide red lactose monohydrate macrogols magnesium stearate methylcellulose microcrystalline cellulose   opacode black s-8-27741 povidone shellac stearic acid sucrose     titanium dioxide   active: conjugated estrogens 0.625mg (15mg as a dessication with lactose. includes 3% overage.) medroxyprogesterone acetate 5mg (includes 4% overage) excipient: calcium sulfate carnauba wax glyceryl mono-oleate indigo carmine lactose monohydrate macrogols magnesium stearate methylcellulose microcrystalline cellulose opacode black s-8-27741 povidone shellac stearic acid sucrose titanium dioxide  

Canada - anglais - Health Canada

bausch health, canada inc. - conjugated estrogens - tablet - 0.625mg - conjugated estrogens 0.625mg - estrogens

Canada - anglais - Health Canada

valeant canada lp / valeant canada s.e.c. - conjugated estrogens - tablet - 1.25mg - conjugated estrogens 1.25mg - estrogens

Canada - anglais - Health Canada

valeant canada lp / valeant canada s.e.c. - conjugated estrogens - tablet - 0.3mg - conjugated estrogens 0.3mg - estrogens

Canada - anglais - Health Canada

valeant canada lp / valeant canada s.e.c. - conjugated estrogens - tablet - 0.9mg - conjugated estrogens 0.9mg - estrogens

Canada - anglais - Health Canada

pfizer canada ulc - conjugated estrogens - powder for solution - 25mg - conjugated estrogens 25mg - estrogens